These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7172499

  • 1. Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.
    Garin EH, Barratt TM.
    Clin Exp Immunol; 1982 Sep; 49(3):639-44. PubMed ID: 7172499
    [Abstract] [Full Text] [Related]

  • 2. Impaired primary antibody response in experimental nephrotic syndrome.
    Garin EH, Sausville PJ, Richard GA.
    Clin Exp Immunol; 1983 Jun; 52(3):595-8. PubMed ID: 6347472
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin synthesis inhibitors and primary antibody response in experimental nephrotic syndrome.
    Garin EH, Richard GA.
    Clin Immunol Immunopathol; 1984 Jan; 30(1):129-33. PubMed ID: 6365379
    [Abstract] [Full Text] [Related]

  • 4. Aminonucleoside nephrosis in rats. Ultrastructural findings in the glomerulus by concomitant influence of indomethacin and aminonucleoside.
    Sessa A, Conte F, Cioffi A, D'Amico GD.
    Nephron; 1975 Jan; 14(3-4):299-308. PubMed ID: 1128753
    [Abstract] [Full Text] [Related]

  • 5. 6 Keto prostaglandin F1alpha plasma levels in aminonucleoside nephrosis in the rat.
    Garin EH, Sausville PJ, Richard GA.
    Prostaglandins; 1982 Mar; 23(3):391-5. PubMed ID: 6896583
    [No Abstract] [Full Text] [Related]

  • 6. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H, Shibuya T, Odashima S, Arichi S, Nagase S.
    Nephron; 1988 Mar; 50(4):351-5. PubMed ID: 3237275
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J, Nakajima K, Ohno Y, Kaneshiro Y, Matsuo T, Tanaka H, Kaneko K.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):239-44. PubMed ID: 18541230
    [Abstract] [Full Text] [Related]

  • 8. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
    Gherardi E, Calandra S.
    Biochim Biophys Acta; 1982 Feb 15; 710(2):188-96. PubMed ID: 7066357
    [Abstract] [Full Text] [Related]

  • 9. Effect of dietary antioxidants on puromycin aminonucleoside nephrotic syndrome.
    Pedraza-Chaverri J, Arévalo AE, Hernández-Pando R, Larriva-Sahd J.
    Int J Biochem Cell Biol; 1995 Jul 15; 27(7):683-91. PubMed ID: 7648424
    [Abstract] [Full Text] [Related]

  • 10. Experimental nephrosis: interassociation of proteinuria with impaired lymphocyte blastogenesis.
    Minchin MA, Bower GD, Turner KJ.
    Clin Exp Immunol; 1981 Feb 15; 43(2):270-5. PubMed ID: 7273481
    [Abstract] [Full Text] [Related]

  • 11. Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats.
    Ulich TR, Meline JA, Ni RX, Keys M, Wu CH.
    Am J Pathol; 1987 Oct 15; 129(1):133-9. PubMed ID: 3499082
    [Abstract] [Full Text] [Related]

  • 12. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J, Weening JJ, Elema JD.
    Lab Invest; 1984 Sep 15; 51(3):277-85. PubMed ID: 6471809
    [Abstract] [Full Text] [Related]

  • 13. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
    Klein DJ, Dehnel PJ, Oegema TR, Brown DM.
    Lab Invest; 1984 May 15; 50(5):543-51. PubMed ID: 6232422
    [Abstract] [Full Text] [Related]

  • 14. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T, Mamo JC, Nagano S, Sugisaki T.
    Nephron; 1991 May 15; 58(1):95-100. PubMed ID: 1857487
    [Abstract] [Full Text] [Related]

  • 15. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E.
    Isr J Med Sci; 1996 Jun 15; 32(6):390-7. PubMed ID: 8682644
    [Abstract] [Full Text] [Related]

  • 16. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats.
    Yu Z, Schumacher M, Frey BM, Frey FJ, Vogt B.
    Nephron Physiol; 2005 Jun 15; 101(3):p51-62. PubMed ID: 16020936
    [Abstract] [Full Text] [Related]

  • 17. Lymphocyte blastogenesis in nephrotic syndrome.
    Minchin MA, Turner KJ, Bower GD.
    Clin Exp Immunol; 1980 Nov 15; 42(2):241-6. PubMed ID: 7471515
    [Abstract] [Full Text] [Related]

  • 18. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
    Kaplan BS, Renaud L, Drummond KN.
    Lab Invest; 1976 Feb 15; 34(2):174-8. PubMed ID: 1249918
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin I-converting enzyme activity in puromycin aminonucleoside-nephrotic syndrome.
    Arévalo AE, Ibarra-Rubio ME, Cruz C, Peńa JC, Pedraza-Chaverrí J.
    Clin Chim Acta; 1990 Nov 05; 191(3):175-84. PubMed ID: 2175683
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH, Boggs KP, Burke FC.
    Int J Pediatr Nephrol; 1985 Nov 05; 6(2):117-20. PubMed ID: 4030221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.